Dermatitis, Eczematous Completed Phase 3 Trials for Alitretinoin (DB00523)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00817063Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand EczemaTreatment
NCT00519675Alitretinoin in the Treatment of Chronic Hand EczemaTreatment